Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.

Miklos Acs Zoltan HeroldAttila Marcell SzaszMax MayrSebastian HäuslerPompiliu Piso

Published in: Cancers (2022)

Increasing data support the value of HIPEC in the treatment of advanced ovarian cancer. Ongoing prospective studies will definitively clarify the role and timing of this additional therapeutic approach.

Keyphrases

minimally invasive
papillary thyroid
coronary artery bypass
electronic health record
squamous cell
locally advanced
big data
radiation therapy
machine learning
acute coronary syndrome